Satiation hormone, neurotensin, linked to increased risk of disease, premature death in women

October 19, 2012
The satiation hormone and women's health
Credit: Shutterstock

Researchers in Sweden have discovered that neurotensin, a satiation hormone produced in the human brain and intestine that circulates in the blood, could raise the risk of heart attack, breast cancer and diabetes in women.

Presented in the (JAMA), the study also found a link between neurotensin and premature death in women, with cardiovascular disease being one of the significant factors. The study sheds fresh light on and preventive treatment research.

'It was surprising to find such a clear link to the risk of and cardiovascular disease, as well as to breast cancer,' said lead author Olle Melander, a professor from the Department of Clinical Sciences at Lund University and a consultant at Skane University Hospital in Sweden. 'Obesity is a common risk factor for all three conditions, but the connection with neurotensin is not explained by obesity or other known risk factors.'

Previous research identified that the hormone plays a role in digestion and pain in the , and animals that were injected with neurotensin
had altered eating habits.

'This is the first time a satiation hormone has been linked to these three in women,' commented co-author Professor Marju Orho-Melander from the Department of Clinical Sciences at Lund University. 'It therefore opens up a new field for continued research on risk assessment and preventive treatment.'

According to the researchers, it is interesting that the findings apply to women only. While information from research on is standard, not much data have been forthcoming about the development of cardiovascular disease in women.

The researchers said the strong association between neurotensin and these conditions in women impacts the life expectancy of women patients. They added that this link adds weight to the idea that neurotensin can be used as a clinical risk marker for these conditions. The findings also offer the medical world new opportunities for early identification of women who are at greater risk of developing cardiovascular disease. The current known do not enable researchers to predict when this disease can occur in women. The findings can make it possible for patients to receive earlier.

'Because the hormone circulates around the body in the blood, levels can be measured with a normal blood test, which is an advantage,' said Professor Melander.

The researchers examined blood samples from more than 4,600 people who participated in the Malmö Diet and Cancer study in Sweden. All subjects gave blood samples over a number of years, making it possible for the researchers to identify a connection between neurotensin levels and the women who later developed one of the three disorders.

Patients who follow a low-fat diet could help reduce neurotensin production, which in turn could potentially regulate neurotensin levels, according to the researchers. But if neurotensin is to work as a target for treatment, a causal relationship must first be established, they added. The researchers believe current genetic studies could help lead to the identification of this relationship.

Explore further: Hormone level linked with increased risk of diabetes, cardiovascular disease, breast cancer, death

More information: Melander, O. et al. 'Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer and mortality', JAMA, 2012. doi:10.1001/jama.2012.12998

Related Stories

Hormone level linked with increased risk of diabetes, cardiovascular disease, breast cancer, death

October 9, 2012
Plasma levels of proneurotensin are associated with the development of diabetes, cardiovascular disease, cardiovascular and total mortality, and breast cancer in women during long-term follow-up, according to a study in the ...

Diabetes and obesity increase risk for breast cancer development

December 7, 2011
Having diabetes or being obese after age 60 significantly increases the risk for developing breast cancer, a Swedish study has revealed. Data also showed that high blood lipids were less common in patients when diagnosed ...

Scientists provide detailed view of brain protein structure: Results may help improve drugs for neurological disorders

October 10, 2012
Researchers have published the first highly detailed description of how neurotensin, a neuropeptide hormone which modulates nerve cell activity in the brain, interacts with its receptor. Their results suggest that neuropeptide ...

Elevated hormone levels add up to increased breast cancer risk

October 21, 2011
Post-menopausal women with high levels of hormones such as estrogen or testosterone are known to have a higher risk of breast cancer. New research published in BioMed Central's open access journal Breast Cancer Research looked ...

Heart disease beats breast cancer as the biggest killer

June 19, 2011
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research ...

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.